Boost your weight-loss journey with Tesamorelin Peptide therapy. Reduce stubborn belly fat safely and effectively with Dynasty Clinic.
Tesamorelin peptide therapy is often searched alongside the word weight loss. That framing isn’t accurate. Tesamorelin targets visceral fat, the fat stored deep around your organs. It doesn’t produce broad weight loss on its own. This guide explains what tesamorelin actually does. It covers who qualifies for treatment, how the therapy works, and what results look like in practice.
What is Tesamorelin Peptide?
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog. It signals your pituitary gland to release more of your body’s own growth hormone. The FDA approved tesamorelin under the brand name Egrifta. Its approved prescribing information limits its use to reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy.
Unveil Your Next Chapter With Dynasty
Our dedicated team is here to answer your questions and guide you on your path to well-being. Get in touch today to schedule a consultation or explore our services.
What Does Tesamorelin Do?
Tesamorelin raises growth hormone levels through your pituitary gland. Higher growth hormone triggers lipolysis, the breakdown of stored fat.
This effect targets visceral fat specifically. Visceral fat sits deep around your organs, not just under your skin. Appetite-suppressing medications work differently, and they drive broader changes on the scale.
Tesamorelin Benefits for Visceral Fat
Clinical trials measured tesamorelin’s effect on visceral fat using CT imaging. One 412-patient trial found a 15.2% reduction in visceral fat over six months.
- Reduced visceral fat around the abdominal organs
- Improved metabolic markers linked to visceral fat
- Preserved lean muscle mass compared to calorie-restriction approaches
- Delivered through a once-daily injection under medical supervision
These benefits apply most clearly to the approved patient population. Results outside that population are still being studied.
Who Tesamorelin Is For
Tesamorelin’s approved use covers adults with HIV-associated lipodystrophy. This condition causes abnormal fat buildup around the abdomen.
Some doctors prescribe tesamorelin off-label for other patients with excess visceral fat. This use is legal but not FDA-approved. Expert doctors at Dynasty Clinic review your health history, current medications, and metabolic profile before recommending any protocol.
How Tesamorelin Peptide Therapy Works
Treatment starts with a consultation. Our medical team reviews your bloodwork, health history, and goals before building a plan. Tesamorelin is administered through a daily subcutaneous injection. Our specialists guide you through injection technique and monitoring as part of our peptide therapy in Dubai programs.
Tesamorelin vs. Weight-Loss Treatments
Tesamorelin is not a weight-loss drug. Its FDA label states it is weight neutral, meaning it doesn’t produce significant changes on the scale on its own. GLP-1 medications like semaglutide work differently. They suppress appetite and drive total body weight loss.
Growth hormone-releasing peptides like CJC-1295 and Ipamorelin share tesamorelin’s mechanism but carry their own approval status and considerations.
If your goal is total body weight loss rather than visceral fat specifically, a different approach may fit better. Our team reviews all fat-reduction peptide options during your consultation.
Side Effects and Safety Monitoring
Tesamorelin carries known side effects. Most are mild and improve as your body adjusts.
- Injection site redness or swelling
- Water retention, especially in early weeks
- Joint discomfort or stiffness
- Elevated blood sugar in patients prone to insulin resistance
Our physicians monitor IGF-1 and glucose levels throughout treatment. This monitoring catches issues early and keeps your protocol safe.
Talk to Our Specialists
Tesamorelin offers a specific, studied approach to visceral fat. It isn’t a general weight-loss shortcut, and understanding that difference helps you set realistic expectations.
Book a consultation with Dynasty Clinic to find out whether tesamorelin peptide therapy fits your health profile.
Book Your Consultation
Curious whether Tesamorelin peptide therapy fits your goals? Our specialists also offer a full range of peptide treatments explore our Peptide Therapy services or read more about Tesamorelin dosing and side effects. Book a consultation with our team to discuss whether this therapy is right for you.
Is tesamorelin the same as a weight-loss drug?
No. Tesamorelin targets visceral fat specifically and is weight neutral on its own label. Total body weight often changes very little.
Is tesamorelin FDA-approved for everyone?
No. Its only approved use is reducing visceral fat in adults with HIV-associated lipodystrophy. Use in other patients is off-label.
How long before I see results from tesamorelin?
Clinical trials measured visceral fat changes over six months. Individual timelines vary based on health history and adherence to the protocol.
Does visceral fat return after stopping tesamorelin?
Yes, in most cases. Visceral fat tends to return toward baseline once treatment stops, so ongoing therapy maintains the effect.
Book an Appointment
It’s easy and free!
